Article

Repurposing statins in combination therapy for effective ablation of metastatic breast cancer

2025-05-28

Abstract excerpt

Metastatic breast cancer (mBC) remains an incurable disease with limited treatment options, highlighting the need for novel therapeutic approaches. Combination therapy with chemotherapeutic agents along with targeted therapy are the most common methods of treatment used in the terminal stages of the disease. Eventual development of resistance to these approaches, leading to fatal outcomes suggests the presence or...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d8fe1cda-7a31-5ea3-80ed-56296161c092
DOI: 10.1101/2025.05.25.655937

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Repurposing statins in combination therapy for effective ablation of metastatic breast cancerDOI 10.1101/2025.05.25.655937Read

Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1Semantic proximity Read

Advances in systemic therapy for metastatic breast cancer: future perspectives.Semantic proximity Read

Phenotypic Heterogeneity Drives Differential Disease Outcome in Triple Negative Breast CancerSemantic proximity Read

Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasisSemantic proximity Read

Targeting metastatic breast cancer: problems and potentialSemantic proximity Read

MACC1—the first decade of a key metastasis molecule from gene discovery to clinical translationSemantic proximity Read

MCL-1 plays an oncogenic role in breast cancer by modulating chemoresistance and stemness properties by activating Wnt/β-cateninSemantic proximity Read

An ALK1-governed monocytic lineage shapes an immunosuppressive landscape in breast cancer metastasesSemantic proximity Read

Genetic Variation in Metastasis-Associated in Colon Cancer-1 and the Risk of Breast Cancer Among the Chinese Han Population: A STROBE-Compliant Observational Study.Semantic proximity Read

Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progressionSemantic proximity Read

Multidrug Resistant Breast Cancer Management in Sub-Saharan Africa: Challenges, Pharmacological Strategies and RecommendationsSemantic proximity Read

Resistance to abemaciclib is associated with increased metastatic potential and lysosomal protein deregulation in breast cancer cellsSemantic proximity Read